Beta-casein Nanoparticles as an Oral Delivery System for Chemotherapeutic Drugs: Impact of Drug Structure and Properties on Co-assembly

Alina Shapira,Yehuda G. Assaraf,Dikla Epstein,Yoav D. Livney

DOI: https://doi.org/10.1007/s11095-010-0222-7

IF: 4.58

2010-08-12

Pharmaceutical Research

Abstract:ABSTRACTPurposeTo develop a novel oral drug delivery system comprising a hydrophobic chemotherapeutic drug entrapped within beta casein (β–CN), a major milk protein, which self-associates into micelles in aqueous solutions. The efficient gastric digestibility of β–CN suggests possible targeting to gastric cancers.MethodsAntitumor drug entrapment was performed by stirring its dimethyl-sulfoxide solution into a phosphate-buffered saline containing β–CN. The association of drugs to β–CN was characterized by spectrophotometry and Trp143 fluorescence quenching; particle-size by dynamic light scattering, and colloidal stability by zeta potential.ResultsThe optimal drug-to-β–CN molar loading-ratios for paclitaxel and vinblastine at 1 mg/ml β–CN were found to be 7.3 ± 1.2 and 5.3 ± 0.6 and the association constants were (6.3 ± 1.0)·103 M−1 and (2.0 ± 0.3)·104 M−1, respectively. Zeta potential analysis suggested that nanoencapsulation by β–CN stabilized all studied drugs in aqueous solution. The initial drug-β–CN association was apparently governed by hydrophobic interactions and at higher drug concentrations, also by electrostatic interactions. Up to the optimal drug:β–CN loading-ratio, ~80% of the particles were below 100 nm in diameter. At higher drug concentrations, particle diameter increased, and bi- or tri-modal particle distributions were observed.ConclusionsBeta–CN forms colloidally-stable nanovehicles of hydrophobic anticancer drugs, and may be used for oral-delivery of chemotherapeutics.

pharmacology & pharmacy,chemistry, multidisciplinary